Summary by Moomoo AI
Merck & Co., Inc. (Merck), a leading pharmaceutical company, filed an amendment to its annual report on Form 10-K/A with the Securities and Exchange Commission on April 11, 2024. This amendment was made to correct the date of the upcoming Annual Meeting of Shareholders, which was previously stated as May 18, 2024, but is actually scheduled for May 28, 2024. The amendment includes changes to Part III, Items 10 through 14, and the cover of the filing, as well as new certifications from the principal executive officer and principal financial officer. The company has confirmed that this amendment does not reflect any events occurring after the original filing or modify any other disclosures, except for the correction of the shareholder meeting date. Merck has also filed all required...Show More